Clinical Trial Update: Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the combination of fludarabine and thalidomide in newly diagnosed chronic lymphocytic leukemia has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Fludarabine (Fludarabine)
• Thalidomide (thalidomide)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-03-05